All news from Anaesthesiology

World’s Deadliest Toxin: New source Discovered

Researchers from the Quadram Institute have identified genes encoding a previously undiscovered version of the botulinum neurotoxin in bacteria from a cow's gut. This is the first time that an intact cluster of genes for making botulinum neurotoxin has been found outside of the bacterium Clostridium botulinum or its close relatives, and only the second report of a new botulinum toxin in the past 40 years.

Aging: UZH leads the largest research

The international research network behind the DO-HEALTH study suggests that one or all three of the affordable and well-tolerated interventions (simple home exercise program, vitamin D supplements, Omega-3 fatty acids) would have an enormous public health impact by enabling senior adults to live a long healthy and active life.

Dengue: Stopping the threat

Improved disease surveillance at Australian ports and borders will help prevent the growing threat of dengue infection spreading, with a new QUT study identifying potential risk factors linked to dengue outbreaks beyond climatic conditions

  1. Improved disease surveillance needed to prevent dengue threat
  2. Social factors linked to trends in dengue outbreaks
  3. Overseas and interstate travelers pose threat in transmission of dengue across Australia
  4. Rainwater tanks, housing style and economic status identified as potential dengue risk factors

FDA Approves First Drug to Treat Inherited Breast Cancer

The U.S. Food and Drug Administration approved the use of Lynparza (olaparib tablets) to treat certain patients with inherited and metastatic breast cancer who have a "BRCA" gene mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer. Patients are selected for treatment with Lynparza based on an FDA-approved genetic test, called the BRACAnalysis CDx.